Clinical Trial Update: Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated adding modulators of homocysteine to adalimumab therapy for moderate to severe plaque psoriasis; the study was terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Wayne State University | Conditions: Psoriasis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-02-04